Search Count: 6
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 2-9
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.57 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: EDO, GOL, A1IS8, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: EDO, GOL, A1IS8, DMS
 |
Human Cdk8/Cyclin-C Complex With Inhibitor 3-7
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.16 Å Release Date: 2025-01-22 Classification: TRANSCRIPTION Ligands: CL, EDO, GOL, A1ITF, DMS |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2025-01-22
Ligands: CL, EDO, GOL, A1ITF, DMS
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-3-Methyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, P4M, MES |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, P4M, MES
 |
C-Terminal Bromodomain Of Human Brd2 With (R)-7-((R)-1,2-Dihydroxyethyl)-1,3-Dimethyl-5-(1-Methyl-1H-Pyrazol-4-Yl)-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, 7PE, P4X |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, 7PE, P4X
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P0U |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, PE4, P0U
 |
C-Terminal Bromodomain Of Human Brd2 With 7,8-Dimethoxy-1,3-Dimethyl-1,3-Dihydro-2H-Benzo[D]Azepin-2-One
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2022-11-30 Classification: TRANSCRIPTION Ligands: EDO, PE4, P3R |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2022-11-30
Ligands: EDO, PE4, P3R